BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jagdish RK, Maras JS, Sarin SK. Albumin in Advanced Liver Diseases: The Good and Bad of a Drug! Hepatology 2021;74:2848-62. [PMID: 33772846 DOI: 10.1002/hep.31836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Jeng LB, Li TC, Hsu SC, Chan WL, Teng CF. Association of Low Serum Albumin Level with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection. J Clin Med 2021;10:4187. [PMID: 34575311 DOI: 10.3390/jcm10184187] [Reference Citation Analysis]
2 Patidar KR, Adibuzzaman M, Naved MA, Rodriquez D, Slaven JE, Grama A, Desai AP, Gomez EV, Ghabril MS, Nephew L, Samala NR, Anderson M, Chalasani NP, Orman ES. Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury. Liver Int 2022;42:187-98. [PMID: 34779104 DOI: 10.1111/liv.15096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Weigand K, Peschel G, Grimm J, Luu K, Schacherer D, Wiest R, Müller M, Schwarz H, Buechler C. Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology. Eur J Immunol 2021. [PMID: 34914098 DOI: 10.1002/eji.202149488] [Reference Citation Analysis]
4 Csak T. Hepatorenal Syndrome. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.013] [Reference Citation Analysis]
5 Li A, Zhou Q, Mei Y, Zhao J, Liu L, Zhao M, Xu J, Ge X, Xu Q. The effect of urinary essential and non-essential elements on serum albumin: Evidence from a community-based study of the elderly in Beijing. Front Nutr 2022;9:946245. [DOI: 10.3389/fnut.2022.946245] [Reference Citation Analysis]